SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Panacea Biotec

BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 25, 16:00
136.75
0.35 (0.26%)
VOLUME 23,163
LIVE
NSE
Jul 25, 15:57
136.95
0.2 (0.15%)
VOLUME 33,340
Announcements on Panacea Biotec

21st-Jul-2016 11:41Source: BSE

Panacea Biotec- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Panacea Biotec Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing O...

20th-Jul-2016 15:49Source: BSE

Panacea Biotec- Shareholding for the Period Ended June 30, 2016

Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly

11th-Jul-2016 13:04Source: BSE

Panacea Biotec- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

Sunanda Jain has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

11th-Jul-2016 12:57Source: BSE

Panacea Biotec- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Sunanda Jain has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

11th-Jul-2016 12:50Source: NSE

Panacea Biotec Limited

Sunanda Jain has submitted to the Exchange vide letter dated July 11, 2016 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

30th-Jun-2016 17:26Source: NSE

Panacea Biotec Limited

Sunanda Jain has submitted to the Exchange vide letter dated June 30, 2016 a copy of disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

30th-Jun-2016 14:29Source: BSE

Panacea Biotec- Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

Sunanda Jain has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011

28th-Jun-2016 14:16Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding a press release dated June 28, 2016, titled "Panacea Biotec Launches- TENEPAN, as cost effective product for the treatment of Type 2 Dabetes ...

28th-Jun-2016 13:05Source: BSE

Panacea Biotec- Panacea Biotec Launches - TENEPAN, a cost effective product for the treatment of Type 2 Diabetes Mellitus (T2DM)

Panacea Biotec Ltd has informed BSE regarding a Press Release dated June 28, 2016 titled "Panacea Biotec Launches - TENEPAN, a cost effective product for the treatment of Type 2 Diabetes Mellitus (T2D...

27th-May-2016 18:54Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.

1 2 3 4 5 Next >>
Quick Links for Panacea Biotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.